2003
DOI: 10.1084/jem.20021825
|View full text |Cite
|
Sign up to set email alerts
|

Paired Activating and Inhibitory Immunoglobulin-like Receptors, MAIR-I and MAIR-II, Regulate Mast Cell and Macrophage Activation

Abstract: Immune responses are regulated by opposing positive and negative signals triggered by the interaction of activating and inhibitory cell surface receptors with their ligands. Here, we describe novel paired activating and inhibitory immunoglobulin-like receptors, designated myeloid-associated immunoglobulin-like receptor (MAIR) I and MAIR-II, whose extracellular domains are highly conserved by each other. MAIR-I, expressed on the majority of myeloid cells, including macrophages, granulocytes, mast cells, and den… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
139
1

Year Published

2005
2005
2015
2015

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 96 publications
(143 citation statements)
references
References 42 publications
(50 reference statements)
3
139
1
Order By: Relevance
“…In humans, KARAP/DAP12 and KIR-S are expressed by CD4 + CD28 -T cells, which expand in patients suffering from chronic inflammatory diseases [25,26]. The activating NK cell receptor Ly49D can be expressed in immature mouse B lymphocytes, whereas myeloid associated immunoglobulin-like receptor II (MAIR-II), also known as leukocyte mono-Ig-like receptor 2 (LMIR-2), is present in LPSstimulated mouse B cells as well as in a subset of mouse peritoneal macrophages [27][28][29]. In T and B lymphocytes, KARAP/DAP12 is preferentially expressed by cells with an activated phenotype that is often related to inflammatory conditions.…”
Section: Karap/dap12 In T and B Lymphocytesmentioning
confidence: 99%
“…In humans, KARAP/DAP12 and KIR-S are expressed by CD4 + CD28 -T cells, which expand in patients suffering from chronic inflammatory diseases [25,26]. The activating NK cell receptor Ly49D can be expressed in immature mouse B lymphocytes, whereas myeloid associated immunoglobulin-like receptor II (MAIR-II), also known as leukocyte mono-Ig-like receptor 2 (LMIR-2), is present in LPSstimulated mouse B cells as well as in a subset of mouse peritoneal macrophages [27][28][29]. In T and B lymphocytes, KARAP/DAP12 is preferentially expressed by cells with an activated phenotype that is often related to inflammatory conditions.…”
Section: Karap/dap12 In T and B Lymphocytesmentioning
confidence: 99%
“…Granulocytes, mast cells, monocytes, and DC all express DAP12 [9]. MDL-1 (myeloid DAP12 associating lectin-1) [10], SIRPb1 (signal-regulatory protein b1) [11], TREM-1 (triggering receptor expressed on myeloid cells-1 ), TREM-2 [1], MAIR-II (myeloid-associated immunoglobulin-like receptor-II) [12], and PILRb [2] have been identified as cell surface receptors that associate with DAP12 in myeloid cells. Recently, members of a novel family of receptors, the CD200R-like receptors, have been found to associate with DAP12 [13].…”
Section: Introductionmentioning
confidence: 99%
“…Paired immune receptors are generally composed of several activating and inhibitory receptors with high homology in the extracellular domains (1,2). We have previously characterized leukocyte mono-Ig-like receptors 1-5 (LMIR1-5) 3 among a novel paired receptor family called LMIR/CMRF-35-like molecules (CLMs)/myeloid-associated Ig-like receptor (MAIR)/ dendritic cell-derived Ig-like receptor (DIgR)/CD300 (3)(4)(5)(6)(7)(8)(9). LMIR3/CLM-1/MAIR-V/DIgR2/CD300LF is an inhibitory receptor that possesses an ITIM in the cytoplasmic region (4,6,7,10,11).…”
mentioning
confidence: 99%